You are in:Home/Publications/Soluble Fas and Bcl-2 (Anti Apopototic Proteins) in Patients with Hashimoto’s Thyroiditis.

Prof. Reem Refaat Abd Elgalil Mohamed Soliman :: Publications:

Title:
Soluble Fas and Bcl-2 (Anti Apopototic Proteins) in Patients with Hashimoto’s Thyroiditis.
Authors: Reem R.Abd El-Glil MD, Ali Hasaneen MD
Year: 2011
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Not Available
Supplementary materials Not Available
Abstract:

Apoptosis, programmed cell death, is a regulating mechanism enabling the removal of superabundantly produced and unnecessary cells. Disturbances of the apoptosis regulation contribute to the pathogenesis of many diseases, including Hashimoto's thyroiditis (HT). Objective: To assess levels of antiapopototic proteins; soluble Fas (sFas) and soluble Bcl-2 (sBcl-2) in sera from patients with HT,evaluate their relationship to antithyroperoxidase antibodies (TPO Ab) and their significance as markers of disease activity. Subjects and Methods: Sera concentration of sFas and sBcl-2 were assayed by Enzyme Linked Immunosorbent Assay (ELISA) in 32 patients with HT (19 with untreated HT, 13 with euthyroid HT) and 15 age-matched healthy adults as a control group. Results: sFas levels were significantly higher in both untreated HT patients (6960±1542 pg/ml) and euthyroid HT patients (6160±1397 pg/mL) compared to controls (5280±938 pg/ml), with p values were

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus